Please try another search
Investing.com - ANI Pharma (NASDAQ: ANIP) reported second quarter EPS of $1.02, $0.08 better than the analyst estimate of $0.94. Revenue for the quarter came in at $138.04M versus the consensus estimate of $128.66M.
ANI Pharma's stock price closed at $59.16. It is down -13.06% in the last 3 months and up 17.43% in the last 12 months.
ANI Pharma saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See ANI Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, ANI Pharma's Financial Health score is "great performance".
Check out ANI Pharma's recent earnings performance, and ANI Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.